Science & Enterprise subscription

Please share Science & Enterprise

Follow by Email
Visit Us

How Smart Street Lighting Saves Power

– Contributed content –

City at night, aerial view

(Peter Nguyen, Unsplash)

16 Nov. 2018. When it comes to solving the world’s climate problem, there are a lot of different ideas on the table. Of course, in the end, a range of these plans are going to have to be used, with efforts coming from all sides to help in this area. When it comes to electricity usage, though, a lot of cities and towns are looking towards just one change to make things a whole lot better; changing the way street lighting works.

To help you out with this, this post will be exploring the differences between this sort of tool can something very similar. With this in mind, it will be easy to see why so many places are looking at this sort of route as they answer.

In the past, the lights being used to illuminate streets and roads would simply stay on as long as it was dark outside. The sensors they had built in wouldn’t be able to tell when people needed the lights or not, wasting loads of power keeping areas lit which aren’t being used for hours at a time. Modern options don’t follow this set of rules. Instead, being able to detect motion, sound, and other inputs, they can remain off until they are needed, turning on to serve people and switching back off after just a few minutes. This can save huge amounts of power, without having to compromise on the good side of street lighting.

Along with being able to turn themselves on and off based on demand, modern street lights also tend to use LEDs rather than the older bulbs which would be found inside them. Reducing power consumption by an estimated 74%, this can be the biggest push a city or town will make towards lowering their footprint on the world.

Like the option above, no one loses out from this sort of arrangement, even with the huge savings in place. This is being considered important enough for governments to fund large-scale switches to this type of bulb, spending huge amounts of money in the process.

These changes to street lighting can already be seen in cities across the world. Everyone from street lighting pole manufacturers to the people installing them are working towards using these new technologies, abandoning the ways which used to work for this sort of resource. Of course, though, it takes more than businesses to make a difference here.

In fact, most of the effort relies on governments to do their part, with a lot of promises being made, but very little action actually being carried out. You can do your part towards helping this by lobbying those in charge in your local area.

Hopefully, this post will show you just how big an impact some small changes can have on this sort of public resource. As time goes on, options like this will become the norm, making it hard to use too much power, even when you are focused on other parts of life. You can even look at similar systems for in your home.

*     *     *

Survey Shows Sharp Rise in Teen E-Cigarette Use

Juul e-cigarette

Juul e-cigarette device (Mylesclark96, Wikimedia Commons)

15 Nov. 2018. New data from a continuing survey of smoking among school-age children shows large increases in electronic cigarette use in high school and middle school children in just the past year. The data are reported today by Centers for Disease Control and Prevention, or CDC, and sparked a robust response from the Food and Drug Administration commissioner Scott Gottlieb.

Electronic cigarettes, or e-cigarettes, are battery-powered nicotine delivery devices, that heat a liquid containing nicotine, moisturizing and flavoring agents, as well as preservatives and artificial coloring. Makers of e-cigarettes often market the devices as safer alternatives to tobacco-burning cigarettes and sometimes as a technique to help tobacco smokers quit conventional cigarettes.

The data were collected as part of the National Youth Tobacco Survey, a continuing study conducted by CDC to document long-term trends in smoking in school-age children, and reported today in CDC’s Morbidity and Mortality Weekly Report. The results show the number of e-cigarette users in high school rose 78 percent to more than 3 million, or about 21 percent of all high school students, since the last survey in 2017. Even among middle school students, e-cigarette smoking jumped by 48 percent in the past year to 570,000 or about 5 percent of all middle school students.

Before 2017, says the CDC report, e-cigarette use by school-age children was declining, and the new marked increase in e-cigarettes is reflected in rising overall use of tobacco by this part of the population. Tobacco use of any kind among high-school students rose in the past year by 38 percent to 4 million, and among middle-schoolers, tobacco use increased by 29 percent to 840,000.

The CDC report authors point to aspects of e-cigarette design that appeal to school-age children for their new popularity. One company, Juul, designs e-cigarettes that resemble flash drives, making them easier to conceal. The authors note also that Juul devices transfer higher quantities of nicotine and use sweet flavors popular with children. An August 2018 report in cites data showing large increases in Juul sales in the past 2 years, making up more than half of all units sold, while sales of other e-cigarette devices are declining.

Since June, FDA issued more than 1,300 warning letters and fines to retailers selling Juul devices to minors and in September — after receiving a preview of today’s data release — began a campaign to reduce teen e-cigarette use. Also in September, FDA asked e-cigarette manufacturers to voluntarily stop offering e-cigarette products in flavors considered attractive to children, limiting flavors to mint and menthol already associated with tobacco.

FDA Commissioner Scott Gottlieb says today in an agency statement, those voluntary steps do not go far enough. He asked FDA’s Center for Tobacco Products to revisit the policy and come up with new measures to prevent children from starting use of e-cigarettes, including stronger age restrictions and verification. While e-cigarettes should still be available for combustible cigarette smokers looking for alternatives, says Gottlieb, e-cigarettes should not be vehicles for recruiting non-smokers, particularly as children. And to reduce flavored options for tobacco, Gottlieb proposed new regulations prohibiting menthol flavored combustible cigarettes and cigars.

In the statement, Gottlieb notes that “the bottom line is this: I will not allow a generation of children to become addicted to nicotine through e-cigarettes. We won’t let this pool of kids, a pool of future potential smokers, of future disease and death, to continue to build. We’ll take whatever action is necessary to stop these trends from continuing.”

More from Science & Enterprise:

*     *     *

Radio Frequency Tags, A.I. Designed to Detect Unsafe Food

Infant formula

Infant formula on store shelves (ParentingPatch, Wikimedia Commons)

15 Nov. 2018. A computer engineering team designed a simple, inexpensive system for detecting food quality with radio-frequency tags applied to consumer products and machine learning algorithms. Researchers from Massachusetts Institute of Technology describe the system in a paper given at this week’s ACM’s HotNets 2018 conference in Redmond, Washington.

Researchers from the Signal Kinetics lab, part of MIT’s Media Lab, led by computer scientist Fadel Adib are seeking more practical ways for consumers to directly assess the quality of food products on store shelves with today’s technologies. The public health issue of food safety is underscored by tainted baby formula, a problem that emerged in China in 2008, and a continuing problem of alcoholic beverages mixed with cheaper industrial methanol leading to blindness in several countries.

“In recent years,” says Adib in an MIT statement, “there have been so many hazards related to food and drinks we could have avoided if we all had tools to sense food quality and safety ourselves. “We want to democratize food quality and safety, and bring it to the hands of everyone.”

One of the everyday wireless technologies proposed for a solution is radio frequency identification, or RFID tags, printed on plastic and applied to increasing numbers of retail items. RFID tags contain identifying and other product data — e.g., size, price, color, location — in a standardized format, which respond to UHF radio signals sent from and transmitted back to a reading device. These so-called passive RFID tags require no additional power source, but respond to electromagnetic signals from the reader on demand. A survey in 2016 showed three-quarters of retailers were implementing RFID tags in their stores.

Adib and colleagues propose employing this technology with no modifications to also gauge product quality. Their idea takes advantage of interactions of the reader’s electromagnetic signals with the contents of the food in the package. These interactions distort the returned signal, and while the distortions do not affect return transmissions of data on the tag, they can be captured and analyzed separately. To capture the returned distorted signals, the researchers modified the readers to receive signals on a wider frequency range.

The team’s system, which they call RFIQ, extracts pertinent data from distortions in the returned signals and sends then to a database in the cloud containing entries of readings from similar food items with RFID tags. The researchers envision manufacturers could provide the initial data for RFIQ. Data from the returned signals would then be transmitted to the database, where they would be evaluated for indications of spoilage or adulteration. Machine learning algorithms, a form of artificial intelligence, would train the initial database, conduct the assessments, and use the submitted data from consumers to refine its analysis over time.

The researchers pilot-tested RFIQ with two types of products, alcohol and infant formula. The team mixed in fixed percentages of methanol — 0, 25, 50, 75, and 100 percent — to pure alcohol in plastic bottles. The team tested the different blends in 3 locations and 10 different bottles. Results show the system returned 97 percent accurate detection of bottles with adulterated alcohol. With infant formula, the researchers added contaminants of melamine — the formula contaminant found in China — in concentrations from 0 to 30 percent to an off-the-shelf brand. The results show 96 percent accurate identification of adulterated formula, missing only the lowest (1.25%) concentration of melamine.

While initial results are promising, say the researchers, a lot of work remains. The team highlights issues with various product types, packaging, signal range, mobility, and power of the machine-learning algorithms that need further study. For further development, the RFIQ system may also beyond safety detection to identifying the nature of the contaminants.

More from Science & Enterprise:

*     *     *

Soda, So Good: The Challenge of Marketing Beverages Today

– Contributed content –

Soft drink bottles


15 Nov. 2018. With every single market currently being over saturated with many more businesses lining up at the start gate, we can feel that every single type of product has been done before. The drinks industry, for example, can feel that it’s overflowing to the point of spilling into other industries and online services, not to mention the fact that traditional stores and bars sell various types of drinks. So if you are looking to market a beverage, is it an uphill struggle, or have you got to think a little bit more about how you promote yourself?

Branding Is everything

The name of a drink can automatically conjure up something in your mind. Right now, Coca-Cola is linked with the famous “holidays are coming” commercials, but there have been brands that struggled with a change of direction- Southern Comfort’s SoCo campaign springs to mind! So when you’re starting out, with the abundance of competition out there now, it’s vital that we get an inherent understanding of our brand before we’ve even begun! And when we are braking on a budget this can be difficult, but with the right digital agencies, product labeling services, and a can-do attitude, we are able to manufacture a prototype ourselves, so what is next?

Market research

It is a fundamental tenet of marketing, to use market research to really drill down exactly what target market would buy the product; you have to invest time and money into market research. To acquire knowledge of your branding, you have to nail down exactly who this product is for. Sometimes it’s self-explanatory, when there are, for example, alcoholic drinks that are flavored like soda, you are immediately targeting the youth market, but for those drinks that can span generations, a little bit more detail is required. Market research is infinitely easier nowadays thanks to Google Analytics, but you can’t rely on tools like this and Facebook Insights to give you a comprehensive picture of the demographics.

Never underestimate word of mouth

Every business has to start somewhere, and with a soft drink or an alcoholic beverage, trying specific target markets with this product and encouraging feedback is going to put you in an advantageous position. The great thing about social media is that word of mouth can gather momentum so quickly. The power of online reviews, especially when done by a social media influencer, can do more for your product and brand then you would have ever thought possible. This is why so many small businesses can make a transcendental leap overnight.

And while social media is a boon for small businesses, it’s not something you can rely on solely. Unifying your brand across multiple platforms certainly works well when it comes to social media, but when you are marketing a drink, the proof is always in the drinking.

It’s incredibly competitive, especially with the major drinks multinationals, and for many companies out there, the dream may very well be to get bored out by one of these bigwigs, but if you’re looking to plot a course yourself, marketing a beverage in the sea of competition is achievable.

*     *     *

Trial Tests Diabetes Mgmt. Program vs. Smartphone Glucose Meter

Livongo meter

Livongo connected blood glucose meter (Livongo Health)

14 Nov. 2018. A new clinical trial is testing a diabetes management program that includes Internet-connected glucose meters and one-on-one coaching against smartphone-enabled glucose meters alone. The study, sponsored by digital medical device company Livongo Health in Mountain View, California, is conducted by University of California in San Francisco.

Livongo Health develops digital systems to help individuals manage diabetes and other chronic health conditions. Diabetes is a chronic disorder where the pancreas does not create enough insulin to process the sugar glucose to flow into the blood stream and cells for energy in the body. In type 2 diabetes, which accounts for at least 90 percent of all diabetes cases, the pancreas produces some but not enough insulin, or the body cannot process insulin. According to the International Diabetes Federation, diabetes affects an estimated 425 million people worldwide, of which 46 million are in North America.

Livongo’s digital systems for managing diabetes, with analytics from data provided by individuals, use the company’s smartphone-based technology. The diabetes management system includes a smart blood glucose meter that connects to cellular networks, and transmits data from the meter to family members, clinicians monitoring the person’s condition, and third-party diabetes counselors certified by Livongo. The meter also collects other data related to the person’s health, such as physical activity.

Data from the smart meter are sent as well to a database in the cloud, where a rules-based inference engine analyzes the data and offers personalized guidance to the individual with diabetes and his or her physician. Livongo users with the mobile app can receive coaching, with tips on nutrition and lifestyle changes, from licensed third-party counselors. People connected to the meter in the Livongo community can provide feedback via voice telephone, e-mail, or text message.

Livongo markets its programs to health plans and employers providing health insurance. The company often studies its user base, including extent of coaching required to achieve results in managing diabetes, and effects on an individual’s health care costs. As reported by Science & Enterprise in June 2018, a Livongo study found program participants receiving intensive coaching as well as using connected glucose meters show more weight loss and lower blood glucose levels.

The new study, however, is an independent assessment, testing Livongo’s program against a digital glucose metering system made by iHealth that connects to a smartphone. The iHealth system also transmits and receives data from the cloud and provides feedback to the user.

The mid-stage clinical trial is recruiting 300 individuals at UC-San Francisco, age 18 and older, with type 2 diabetes. Participants must have an iPhone or access to WiFi, but not be users of continuous glucose monitors or insulin pumps. Those enrolled in the trial will be randomly assigned to take part in the Livongo Health program or use the iHealth smartphone-connected meter for 6 months.

The study team, led by UC-San Francisco pediatric endocrinologist Jenise Wong, will measure participants’ hemoglobin A1c, or HbA1c, levels at the beginning of the study, then after 3 and 6 months. Researchers will also measure lipid levels in the blood, a test for total cholesterol. “We are interested to see how an innovative solution like Livongo truly impacts people,” says Wong in a Livongo statement. “By conducting a randomized controlled trial, we can better understand the degree to which innovative offerings improve health outcomes.”

More from Science & Enterprise:

*     *     *

DNA-Encoded Synthetic Antibodies Protect Against Ebola

Ebola virus

Ebola virus (

14 Nov. 2018. Synthetic antibodies derived from survivors of Ebola infections are shown to be quick and simple to develop, and in lab mice to provide long-term protection against against Ebola viruses. Researchers from the Wistar Institute in Philadelphia and Inovio Pharmaceuticals in San Diego report their findings in yesterday’s issue of the journal Cell Reports.

A team led by immunologist David Weiner, director of the institute’s Vaccine & Immunotherapy Center, is seeking faster and easier methods to make vaccinations against the Ebola virus. A new Ebola outbreak is taking place in Democratic Republic of the Congo, which World Health Organization as of 12 November reports 301 confirmed cases and 174 deaths, with more probable cases and deaths likely. The 2014-15 outbreak in West Africa, according to WHO, reported more than 28,600 cases and 11,300 deaths.

From the previous outbreak, a number of treatment and vaccine candidates emerged, including a group of synthetic targeted antibodies developed by Mapp Biopharmaceutical known as ZMapp. These engineered antibodies were shown in lab animals and early experience with humans to protect against Ebola infections. However, patients required frequent high-dose infusions for the synthetic antibodies to remain effective, and current development and production methods were likewise slow and complex. It became clear to health authorities that more efficient processes were needed should another large-scale Ebola outbreak occurred.

One result of the earlier West Africa experience is more than 10,000 individuals who survived their infections. From their exposure to Ebola, these individuals likely developed natural antibodies against further infections. Weiner and colleagues captured some of these antibodies from survivors and combined them with ZMapp’s engineered antibodies to create new Ebola antibodies.

These DNA-encoded antibodies were created with a process that Inovio Pharmaceuticals licensed from Weiner’s lab while he was at University of Pennsylvania. In this process, called DMab — short for DNA monolclonal antibody — DNA fragments are ingested into cells, where they’re exposed to mild electrical pulses, called electroporation, that increases the uptake of DNA to generate more antibodies. Weiner is a scientific adviser to Inovio.

In September 2015, Science & Enterprise reported on a clinical trial of synthetic targeted antibodies developed with this process to clear up cervical lesions or sores before they become cancerous, which found women receiving the vaccine eradicated more of these lesions than those receiving a placebo.

In the new study, the researchers generated synthetic antibodies with viral DNA, which in lab mice protect against the Ebola virus. The team produced 26 types of DMabs that connected to specific binding targets, known as epitopes, on the virus. In tests with mice, one of the better performing DMabs protected the animals given the Ebola virus. After 82 days following exposure to Ebola, 40 percent of the mice continued to survive.

To counteract Ebola outbreaks, health authorities need to administer vaccines quickly to large populations. The researchers found their process could quickly produce DMabs, which they says is limited only by availability of the latest viral DNA from the scene. “The DMAb platform,” says Weiner in a Wistar statement, “allows us to collect protective antibodies from protected persons and engineer and compare them rapidly and then deliver them in vivo to protect against infectious challenge. Such an approach could be important during an outbreak, when we need to design, evaluate and deliver life-saving therapeutics in a time-sensitive manner.”

More from Science & Enterprise:

*     *     *

Protecting Your Startup

– Contributed content –

Open sign


14 Nov. 2018. Starting your own business is a fantastic achievement. It’s exciting, nerve-wracking, daunting and stressful. It’s challenging and exhilarating. It’s your chance to create the company that you’ve always wanted. To do things your way, to make a difference and to work doing something that you love. Many people dream of starting up on their own, and in today’s world, more people than ever before are able to turn that dream into a reality.

Starting your own business takes an awful lot of time and effort. You might find yourself working six or seven day weeks for months. You might be unable to take holidays or even clock off at a sensible hour. Your to-do lists might be pages and pages long for the first few months of your business, and you might feel as though it has completely taken over your life.

Wouldn’t it be terrible if all of that hard work, time and money, was for nothing? If your business fell at the first hurdle because you failed to take the appropriate steps to protect it from the offset? Because you failed to do your research, to spend time reading advice from LegalZoom or seeking help elsewhere?

Unfortunately, many new businesses make exactly these mistakes. They get caught up in the excitement of starting up, and they neglect to offer themselves and their business the protection that it needs to grow and flourish. Here are some of the steps that you should take to ensure that you are not one of them.


Getting the right insurance is an absolute must for all business. No matter how big or small. What you need, however, will vary. If you run a small business from home, you might simply need to add the value of the equipment that you use to your home insurance policy. If you have any contact with the public at all, liability insurance can be a good idea, and small business insurance is often a wise investment. Learn more about the different types of coverage available to a small business in your field, and take out any premiums that you need.

Online security

You’ve probably taken care of offline security with actions like installing quality locks and CCTV cameras. But, what about online security? Even if your business is brick and mortar based, you probably still use social media, have a website and bank online. This means that you need to be worried about cybercrime and hacking. Install the relevant security plugins on your site, update all of your software and be vigilant with passwords.


If you are unfamiliar with trademarks, copyrights, and patents, it can all be very confusing, and it’s often hard to know what you need. But, all of these documents exist to protect your business, your products, and even your ideas. Research the law to find out which documents you should be applying for and make sure you do it as soon as possible to offer your business, and it’s future key protection.


Starting a business is terribly exciting, and you might want to shout it to the world. But, be careful about what you say and who you say it to. Certainly, before you’ve got other legal protections in place. Discretion and common sense can go a long way to protecting a new business.

*     *     *


Biotechs to Develop Personal Cancer-Killing Virus Vaccines

Adenovirus illustration

Adenovirus illustration (Richard Feldmann, National Cancer Institute)

13 Nov. 2018. Two biotechnology companies developing engineered viruses as cancer therapies plan to create personalized treatments for solid tumors with viruses that harness the immune system. Financial and intellectual property aspects of the agreement between DNAtrix in Houston and Valo Therapeutics in Helsinki, Finland were not disclosed.

Both DNAtrix and Valo Therapeutics use adenoviruses as therapeutic devices to treat cancer. To most people, adenoviruses are benign, but they can cause symptoms similar to the common cold or other viral diseases. DNAtrix develops what it calls “armed viruses,” adenoviruses engineered to enhance and invoke immune-system responses to attack tumor cells. The armed viruses attack tumors directly, but also stimulate T-cells in the immune system to kill tumor cells.

The company, a spin-off enterprise from MD Anderson Cancer Center, currently designs adenovirus treatments for tumors expressing proteins known as tumor necrosis factor receptors, associated with breast, melanoma, brain, and lung cancer. DNAtrix says it successfully tested these treatments in lab animals and has one therapy called tasadenoturev, or DNX-2401, in a clinical trial among patients with the deadly brain cancer glioblastoma. As reported by Science & Enterprise in February, the trial reported mixed results, with dramatic efficacy among some patients, but limited results for others. The company is recruiting participants for other clinical studies of DNX-2401 in patients with brain cancer both alone and with other cancer drugs.

Valo Therapeutics, a spin-off enterprise from University of Helsinki founded in January 2017, also develops cancer immunotherapies with adenoviruses, but modifies the viruses with cancer-killing peptides, short chains of amino acids resembling simple proteins. In the company’s technology known as Pepticrad, the capsid, or viral shell, absorbs the peptides into the virus, turning the virus into a antigen that provokes an immune response specific to the targeted tumor. Valo advanced the technology so multiple peptides can be included into a single virus, including neoantigens, peptides expressed by individual cancer patients’ tumors.

DNAtrix and Valo are collaborating on development of adenovirus cancer vaccines that combine the armed viruses from DNAtrix with Valo’s personalized neoantigen peptides, to provide cancer therapies addressing the precise molecular composition of a patient’s tumor. Frank Tufaro, CEO of DNAtrix, notes in a joint statement, “For the first time, we can combine the potent tumor killing and immune stimulation triggered by viruses along with a patient specific anti-tumor vaccine for generating effective anti-tumor immunity. Perhaps most importantly, the process eliminates the need to manufacture new viruses for each patient.” Tufaro adds, “We are moving swiftly into the clinic to evaluate this exciting technology.”

More from Science & Enterprise:

*     *     *

RNA Therapeutics Company Raises $30M in First Venture Round

Kevin Weeks

Kevin Weeks (Lars Sahl, Univ of North Carolina – Chapel Hill)

13 Nov. 2018. A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells. Ribometrix, a 3 year-old enterprise in Durham, North Carolina, is co-founded by University of North Carolina chemistry professor Kevin Weeks in Chapel Hill, on whose research the company’s technology is based.

Weeks’s lab studies the chemical structure of ribonucleic acid, or RNA molecules, the genetic material transcribed from genetic codes in DNA that provide instructions for protein production in cells. The lab’s researchers look particularly at the three-dimensional folding of RNA in cells, bringing together a range of disciplines including organic chemistry, biophysics, bioinformatics, and computational biology. Weeks is a pioneer in organizing and applying this branch of chemistry — known as selective 2?-hydroxyl acylation analyzed by primer extension, or SHAPE — that measures the structure and dynamics of RNA in assembling proteins.

Research by Weeks and colleagues shows the 3-D structure of RNA reveals identifiable targets for small molecule, or low molecular weight, chemicals that can harness RNA to create therapies for disease. Weeks and Ribometrix co-founder Katherine Warner describe targeting these RNA pockets in a July 2018 article in the journal Nature Reviews Drug Discovery (paid subscription required). Weeks and Warner say these binding targets offer a way to address diseases resulting from so-called undruggable proteins, which is the core of Ribometrix’s corporate strategy. Warner is the company’s research director, while Weeks is an adviser and stockholder. Christine Hajdin, Ribometrix’s screening director, is a co-author of the article.

Michael Solomon, also a Ribometrix co-founder and current CEO, says in a company statement, “A huge medical opportunity awaits RNA-targeting small molecules that can be designed in a systematic fashion, analogous to discovery methods currently employed for protein targets.” While Solomon adds that ” we are well positioned to advance a broad pipeline of compelling drug programs,”

Ribometrix has so far not revealed its current product pipeline, although the Dementia Discovery Fund is an early and continuing investor. A story about the company on the university’s web site in March 2018, quotes Weeks and Warner that Huntington’s disease, a fatal genetic disorder, is a condition the company plans to address. In addition, Weeks is on the faculty at the UNC-Chapel Hill medical school’s cancer center.

The company’s first venture funding round is raising $30 million, led by M Ventures, based in Amsterdam and a subsidiary of drug maker Merck, with participation by the venture investment arms of biopharmaceutical company Amgen and genomics technology developer Illumina, as well as venture investor Pappas Capital, all new investors. Also joining the financing round are Ribometrix’s seed-round funders SV Health Investors, AbbVie Ventures, Hatteras Venture Partners, MP Healthcare Venture Management, the Dementia Discovery Fund, and Alexandria Venture Investments. The company’s seed round raised $7.5 million.

More from Science & Enterprise:

Hat tip: Endpoints News

*     *     *

Becoming a Well-Rounded Entrepreneur Right Now

– Contributed content –

Meeting around a laptop

(Brooke Cagle, Unsplash)

13 Nov. 2018. Your goal in life is to become a widely respected and well-rounded entrepreneur, so that you can grow your small business into an empire one day. You are willing to learn about everything and anything there is to know about your industry so that you can become the best business owner there can possibly be. You want to speed up your career progression so that you have a clear pathway for your future.

Instead of feeling lost and unfocused you will have huge opportunities ahead of you because you are thrusting yourself right into the center of everything that matters in your career. Use the following pointers and you will have a much brighter future ahead of you.

Open up your mind

It’s time to start opening up your mind and exploring all of the opportunities available to you. You can start by using the internet to your advantage, by reading articles, listening to podcasts and watching videos. You will be able to discover all sorts of informative videos from Tully Rinckey here on their channel. Use other people’s experience and knowledge to get you on step ahead in your career. You would be surprised at how much you can learn from other people’s business ventures and real life experiences, so apply this to your own life and see where it takes you.

Try something new

You might have your ideal career set in stone in your mind, but what’s the harm in trying something a little bit different for a change? You might discover an underlying passion for another domain or industry that you might be perfect for. You will never know unless you try, so step out of your comfort zone and into something a little more challenging. Every budding entrepreneur should be willing to get their hands dirty and get stuck into something completely alien to them, so take this opportunity to advance your skills right now.

Listen to advice

Sometimes you just need to become a better listener and understand that others might know more than you. Don’t close your mind and retreat into your shell when you are trying something new; listen to other people and take their advice on board at all times. You might just be able to learn from their mistakes so that you don’t have a rocky and troubled path ahead. People who have been in your industry for a long time will be able to provide you with worthwhile advice, so open up your ears and be prepared to listen.

Never stop learning

Even when you have reached your career goals, you need to understand that your journey isn’t over. There will always be new facts to learn and updates within your industry to get a grasp of. If you have the ability to keep your mind open and never stop learning, you will always be in a much better place to progress.

All of these ideas will help you to become a well-rounded entrepreneur right from the very beginning of your business venture.

*     *     *